• Research Scientist III

    Job ID 2018-29116
    Area of Interest
    Research & Development
    Location Name
    307 Westlake
    FTE/Hours per pay period
    1.0 FTE (80 hours per bi-weekly pay periods)
    Work Status
    Global Infectious Disease
    Day Shift
  • Overview

    Responsible for independently evaluating, selecting, and applying standardized scientific procedures and techniques to carry out research/development activities in a project focused on malaria vaccine development. Has broad knowledge of principles, practices and procedures of immunology, vaccine development, or infectious diseases.  Prior experience in working with malaria models is not necessary, but desirable.  Expertise in the development of vaccine candidates, assessments of vaccine immunity and efficacy, and the techniques needed for in depth study of vaccine-elicited immunity is highly desirable.  Ability or desire to work with murine models is required. Relies on experience and judgment to plan and accomplish goals. Makes detailed observations, analyzes and interprets data and independently writes manuscripts/grant proposals. Collaborates with principal investigator, taking direct responsibility for carrying out research and development activities. Considerable effort (25% or more) may be dedicated to seeking independent outside research funding.


    Required Education/Experience:
    - Master’s Degree or higher in a scientific discipline, or a related field; may require a PhD for certain lab specialties.
    - Minimum of three (3) years experience in a related area of scientific study.
    - Experience analyzing data using imaging software.
    - Experience with laboratory coordination.

    - PhD in molecular or cellular biology, biochemistry, neuroscience, or a related area
    - Substantial prior experience in biochemistry, molecular biology, and tissue culture techniques
    - Familiarity with mouse brain development.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed